Publication:
Appropriateness of antibiotic use in the emergency department: a five-year retrospective study in a region with high antibiotic consumption

dc.contributor.coauthorKaçmaz, B.
dc.contributor.coauthorÖzgürel, T.
dc.contributor.coauthorBakır, E.
dc.contributor.departmentSchool of Medicine
dc.contributor.departmentKUISCID (Koç University İşbank Center for Infectious Diseases)
dc.contributor.kuauthorErgönül, Önder
dc.contributor.kuauthorKeske, Şiran
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.contributor.schoolcollegeinstituteResearch Center
dc.date.accessioned2026-07-17T08:28:33Z
dc.date.issued2026
dc.description.abstractWe aimed to evaluate the use of antibiotics for upper respiratory tract infections (URTIs), particularly during the COVID-19 pandemic in an emergency department (ED), by assessing adherence to the clinical pathway implemented seven years ago. Methods We performed a retrospective study from 2018 to 2022 and included patients with URTIs only in April and November of each year to control for temporal bias. Results A total of 1,683 patients with URTIs were included. We found that 242 of 1,683 (14.3%) patients were administered or prescribed antibiotics in the ED, and 214 of 1,683 (12.7%) had clinical pathway non-adherence. Of the 242 patients, 136 (56.2%) were female, and the mean age was 37.8 (SD: 0.94). The most frequent diagnoses were acute tonsillopharyngitis (55%) and cold/non-specific URTIs (38.4%), respectively. The Streptococcus pyogenes rapid antigen test was positive in 23 of 133 (17.2%) patients with acute tonsillopharyngitis, and 4 of 133 patients had a 4-point Centor score. The first choice of antibiotics was beta-lactams. In multivariate analysis, the predictors of appropriate antibiotic use among patients were acute tonsillopharyngitis (OR: 17.8, CI 3.96-80.1, p
dc.description.harvestedfromManual
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.publisherscopeInternational
dc.description.readpublishN/A
dc.description.sponsoredbyTubitakEuN/A
dc.description.versionPublished Version
dc.identifier.ScopusPercentile41
dc.identifier.ScopusQuartileQ3
dc.identifier.WoSPercentile25.9
dc.identifier.WoSQuartileQ3
dc.identifier.doi10.1016/j.diagmicrobio.2026.117463
dc.identifier.eissn1879-0070
dc.identifier.embargoN/A
dc.identifier.issn0732-8893
dc.identifier.issue2
dc.identifier.pubmed42190527
dc.identifier.scopus2-s2.0-105039775836
dc.identifier.urihttp://doi.org/10.1016/j.diagmicrobio.2026.117463
dc.identifier.urihttps://hdl.handle.net/20.500.14288/33390
dc.identifier.volume116
dc.identifier.wos001783707000001
dc.keywordsAntibiotic use
dc.keywordsAntimicrobial resistance
dc.keywordsCOVID-19
dc.keywordsUpper respiratuary tract infection
dc.languageeng
dc.publisherElsevier
dc.relation.affiliationKoç University
dc.relation.collectionKoç University Institutional Repository
dc.relation.ispartofDiagnostic Microbiology and Infectious Disease
dc.relation.openaccessN/A
dc.rightsN/A
dc.rights.uriN/A
dc.subjectInfectious diseases
dc.subjectMicrobiology
dc.titleAppropriateness of antibiotic use in the emergency department: a five-year retrospective study in a region with high antibiotic consumption
dc.typeJournal Article
dspace.entity.typePublication
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication09525e58-d4ea-4461-b2ec-f131e54c0771
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublicationd437580f-9309-4ecb-864a-4af58309d287
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files